Mon, September 23, 2019
Fri, September 20, 2019
Thu, September 19, 2019
Wed, September 18, 2019
Tue, September 17, 2019
Mon, September 16, 2019
Fri, September 13, 2019
Thu, September 12, 2019
Wed, September 11, 2019
Tue, September 10, 2019
Mon, September 9, 2019
Fri, September 6, 2019
Thu, September 5, 2019
Wed, September 4, 2019
Tue, September 3, 2019
Fri, August 30, 2019
Thu, August 29, 2019

Sumant Kulkarni Upgraded (ACAD) to Strong Buy on, Sep 10th, 2019


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. pgraded-acad-to-strong-buy-on-sep-10th-2019.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Sumant Kulkarni of Canaccord Genuity, Upgraded "ACADIA Pharmaceuticals Inc." (ACAD) to Strong Buy on, Sep 10th, 2019.

Sumant has made no other calls on ACAD in the last 4 months.



There are 4 other peers that have a rating on ACAD. Out of the 4 peers that are also analyzing ACAD, 1 agrees with Sumant's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Paul Matteis of "Stifel" Maintained at Hold with Increased Target to $28 on, Tuesday, September 3rd, 2019


These are the ratings of the 3 analyists that currently disagree with Sumant


  • Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $60 on, Monday, September 9th, 2019
  • Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy with Increased Target to $40 on, Tuesday, August 27th, 2019
  • Danielle Brill of "Raymond James" Reiterated at Strong Buy with Increased Target to $43 on, Friday, May 31st, 2019

Publication Contributing Sources